Next Article in Journal
Genetic Variants in SDC3, KCNA2, KCNK1, KCNK16, and Heat Shock Transcription Factor-1 Genes: An Exploratory Analysis Supporting the Piezo2 Channelopathy Hypothesis in Amyotrophic Lateral Sclerosis Onset
Previous Article in Journal
Correction: Wang et al. Molecular Dissection of TaLTP1 Promoter Reveals Functional Cis-Elements Regulating Epidermis-Specific Expression. Int. J. Mol. Sci. 2020, 21, 2261
Previous Article in Special Issue
Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Enríquez-Rodríguez et al. Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients. Int. J. Mol. Sci. 2025, 26, 6373

by
César Jessé Enríquez-Rodríguez
1,2,3,†,
Bella Agranovich
4,
Sergi Pascual-Guàrdia
1,2,3,
Rosa Faner
3,5,
Ramon Camps-Ubach
1,2,3,
Ady Castro-Acosta
6,
José Luis López-Campos
3,7,
Germán Peces-Barba
3,8,
Luis Seijo
3,8,9,
Oswaldo Antonio Caguana-Vélez
1,2,
Diego Rodríguez-Chiaradia
1,2,3,
Esther Barreiro
1,2,3,
Eduard Monsó
3,10,
Borja G. Cosío
3,11,
Ifat Abramovich
4,
Alvar Agustí
3,5,
Carme Casadevall
1,2,3,‡,
Joaquim Gea
1,2,3,*,‡ and
on behalf of the BIOMEPOC Group
§
1
Hospital del Mar Research Institute, Servei de Pneumologia, Hospital del Mar, 08003 Barcelona, Spain
2
MELIS Department, Universitat Pompeu Fabra, 08003 Barcelona, Spain
3
Centro de Investigación Biomédica en Red, Área de Enfermedades Respiratorias (CIBERES), ISCiii, 28029 Madrid, Spain
4
The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa 3525433, Israel
5
Servei de Pneumologia (Institut Clínic de Respiratori), Hospital Clínic—Fundació Clínic per la Recerca Biomèdica, Universitat de Barcelona, 08036 Barcelona, Spain
6
Servicio de Neumología, Hospital 12 de Octubre, 28041 Madrid, Spain
7
Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocío, Universidad de Sevilla, 41012 Sevilla, Spain
8
Servicio de Neumología, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, 28049 Madrid, Spain
9
Servicio de Neumología, Clínica Universidad de Navarra, 28027 Madrid, Spain
10
Fundació Institut d’Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Spain
11
Servicio de Neumología, Hospital Son Espases, Institut d’Investigació Sanitària Illes Balears (IdISBa), Universitat de les Illes Balears, 07120 Palma, Spain
*
Author to whom correspondence should be addressed.
This author is a recipient of a Predoctoral Grant PFIS from ISCIII, co-funded by the European Union (ref. FI22/00003).
These authors contributed equally as the senior author of this work.
§
See the Appendix A for members of the group.
Int. J. Mol. Sci. 2025, 26(20), 10217; https://doi.org/10.3390/ijms262010217
Submission received: 1 October 2025 / Accepted: 7 October 2025 / Published: 21 October 2025

Error in Table 4

In the original publication, the authors identified a mistake in Table 4 as published [1]: the values in Table 4 were duplicated from Table 3. The corrected Table 4 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Appendix A

Members of the BIOMEPOC group (in alphabetical order): Mireia Admetlló, Alvar Agustí, Carlos Alvarez-Martínez, Esther Barreiro, Oswaldo Antonio Caguana, Carme Casadevall, Ferran Casals, Robert Castelo, Ady Castro-Acosta, Rocío Córdova, Borja G Cosío, Rosa Faner, Laura I Furlong, Marian García, José G. González-García, Carmen Hernández-Carcereny, José Luis López-Campos, Eduardo Márquez, Eduard Monsó, Concepción Montón, Miren Josune Ormaza, Alexandre Palou, Sergi Pascual, Germán Peces-Barba, Pau Puigdevall, Diego A. Rodríguez-Chiaradia, Ferran Sanz, Luis Seijo, Montserrat Torà, Yolanda Torralba, and Carles Vilaplana.

Reference

  1. Enríquez-Rodríguez, C.J.; Agranovich, B.; Pascual-Guàrdia, S.; Faner, R.; Camps-Ubach, R.; Castro-Acosta, A.; López-Campos, J.L.; Peces-Barba, G.; Seijo, L.; Caguana-Vélez, O.A.; et al. Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients. Int. J. Mol. Sci. 2025, 26, 6373. [Google Scholar] [CrossRef] [PubMed]
Table 4. Comparison of prediction models using conventional DAMs versus AI-based free metabolite selection combined with FEV1 integration.
Table 4. Comparison of prediction models using conventional DAMs versus AI-based free metabolite selection combined with FEV1 integration.
Conventional + FEV1AI Free Choice + FEV1
Fitting
   Sensitivity–Specificity–MCC1.001.00
   Coverage1.001.00
Prediction
   Sensitivity0.831.00
   Specificity1.000.92
   MCC0.830.92
   Coverage0.850.96
   PPV (rep/our)1.00/1.000.92/0.86
   NPV (rep/our)0.87/0.931.00/1.00
   Accuracy (rep/our)0.92/0.950.96/0.95
PPV: NPV and accuracy were calculated based on either (a) the mortality observed in our COPD cohort (32%) [our] or (b) the mortality rate previously reported [rep] in the Spanish COPD population (47%) [11], which aligns with mortality predictions derived from the 3CIA initiative detailed in Appendix B [6,12]. Abbreviations: MCC: Matthews correlation coefficient; PPV: positive predicted value; NPV: negative predicted value; rep: reported mortality; our: our own mortality; AI: artificial intelligence.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Enríquez-Rodríguez, C.J.; Agranovich, B.; Pascual-Guàrdia, S.; Faner, R.; Camps-Ubach, R.; Castro-Acosta, A.; López-Campos, J.L.; Peces-Barba, G.; Seijo, L.; Caguana-Vélez, O.A.; et al. Correction: Enríquez-Rodríguez et al. Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients. Int. J. Mol. Sci. 2025, 26, 6373. Int. J. Mol. Sci. 2025, 26, 10217. https://doi.org/10.3390/ijms262010217

AMA Style

Enríquez-Rodríguez CJ, Agranovich B, Pascual-Guàrdia S, Faner R, Camps-Ubach R, Castro-Acosta A, López-Campos JL, Peces-Barba G, Seijo L, Caguana-Vélez OA, et al. Correction: Enríquez-Rodríguez et al. Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients. Int. J. Mol. Sci. 2025, 26, 6373. International Journal of Molecular Sciences. 2025; 26(20):10217. https://doi.org/10.3390/ijms262010217

Chicago/Turabian Style

Enríquez-Rodríguez, César Jessé, Bella Agranovich, Sergi Pascual-Guàrdia, Rosa Faner, Ramon Camps-Ubach, Ady Castro-Acosta, José Luis López-Campos, Germán Peces-Barba, Luis Seijo, Oswaldo Antonio Caguana-Vélez, and et al. 2025. "Correction: Enríquez-Rodríguez et al. Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients. Int. J. Mol. Sci. 2025, 26, 6373" International Journal of Molecular Sciences 26, no. 20: 10217. https://doi.org/10.3390/ijms262010217

APA Style

Enríquez-Rodríguez, C. J., Agranovich, B., Pascual-Guàrdia, S., Faner, R., Camps-Ubach, R., Castro-Acosta, A., López-Campos, J. L., Peces-Barba, G., Seijo, L., Caguana-Vélez, O. A., Rodríguez-Chiaradia, D., Barreiro, E., Monsó, E., Cosío, B. G., Abramovich, I., Agustí, A., Casadevall, C., Gea, J., & on behalf of the BIOMEPOC Group. (2025). Correction: Enríquez-Rodríguez et al. Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients. Int. J. Mol. Sci. 2025, 26, 6373. International Journal of Molecular Sciences, 26(20), 10217. https://doi.org/10.3390/ijms262010217

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop